CD34+ stem cell therapy in nonischemic dilated cardiomyopathy patients.
about
Intravitreal autologous bone marrow CD34+ cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findingsGenerating patient-specific induced pluripotent stem cells-derived cardiomyocytes for the treatment of cardiac diseases.Evolving targeted therapies for right ventricular failure.Endothelial and Astrocytic Support by Human Bone Marrow Stem Cell Grafts into Symptomatic ALS Mice towards Blood-Spinal Cord Barrier RepairHeart failure: a disease complex with challenging therapeutics.
P2860
CD34+ stem cell therapy in nonischemic dilated cardiomyopathy patients.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
CD34+ stem cell therapy in nonischemic dilated cardiomyopathy patients.
@en
type
label
CD34+ stem cell therapy in nonischemic dilated cardiomyopathy patients.
@en
prefLabel
CD34+ stem cell therapy in nonischemic dilated cardiomyopathy patients.
@en
P2093
P2860
P356
P1476
CD34+ stem cell therapy in nonischemic dilated cardiomyopathy patients
@en
P2093
P2860
P304
P356
10.1038/CLPT.2013.134
P407
P577
2013-07-31T00:00:00Z